Delivery Order SPE2DB20D3103-SPE2DB25FP6R2
Award Date 7/28/25
Potential Completion Date 7/29/25
Potential Value $2.3K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,374.60 for Cathflo Activase 2 mg vials, effective July 24, 2025, with an ultimate completion date of July 25, 2025. This firm fixed price delivery order was awarded without a set-aside designation through open competition and will be performed at the contractor's Conshohocken, Pennsylvania facility. Cathflo Activase is a thrombolytic agent used in medical settings to restore function to occluded...
- The Defense Logistics Agency awarded a delivery order valued at $12,949.43 to AmerisourceBergen Drug Corp for the supply of Cathflo Activase 2 mg vials under a firm fixed-price contract. This non-set-aside award, issued on July 28, 2025, with an ultimate completion date of July 29, 2025, represents a routine pharmaceutical procurement from the prime contractor's corporate office located in Conshohocken, Pennsylvania. The delivery order is executed under AmerisourceBergen Drug Corp's larger...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $12,558.77 by the Defense Logistics Agency on July 21, 2025, for the supply of Cathflo Activase 2 mg vials. This contract is structured as a firm fixed price delivery order with no set-aside designation, indicating it was awarded through open competition. The ultimate completion date is scheduled for July 22, 2025, with performance occurring at the contractor's Conshohocken...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide Cathflo Activase 2 mg vials. The contract has a ceiling value of $2,570.16 and a period of performance through March 14, 2024. AmerisourceBergen Drug Corp is the prime contractor and there is no set-aside designation. This delivery order is part of a larger $999,999,999.00 indefinite delivery contract (IDC) awarded...
- This delivery order, valued at $4,524.80, was awarded to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Cathflo Activase 2 mg vials. The contract is a firm fixed price, non-set-aside award funded by the Defense Logistics Agency (DLA) and is scheduled for completion by July 21, 2025. AmerisourceBergen will perform the work at its corporate office location in Conshohocken, Pennsylvania. This delivery order represents a discrete purchase under the company's broader pharmaceutical...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a $3,197.14 firm fixed price delivery order contract by the Defense Logistics Agency (DLA) Troop Support Medical to supply CATHFLO ACTIVASE 2 MG VIALS. This delivery order is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 awarded by DLA to Amerisourcebergen Drug Corp as the sole prime contractor. The IDC, which does not fall under any overarching contract...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a $28,627.71 firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide CATHFLO ACTIVASE 2 MG VIALS. The contract has a completion date of May 10, 2022 and does not have a set-aside designation. Amerisourcebergen Drug Corp is the prime contractor, with no major subcontractors mentioned. This delivery order is part of a larger indefinite delivery contract (IDC) valued at...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,090.40, is for the delivery of 2 mg vials of Cathflo Activase, a medication used to treat certain blood clots. The contract has an ultimate completion date of April 11, 2025 and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug...
- The Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a firm fixed price delivery order contract worth $10,917.12 to provide CATHFLO ACTIVASE 2 MG VIALS. This delivery order is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00 that runs through December 31, 2025, which serves as the primary vehicle for Amerisourcebergen to deliver pharmaceuticals and medical supplies to DLA Troop Support Medical...
- The Defense Logistics Agency awarded a delivery order valued at $22,365.75 to AmerisourceBergen Drug Corp for the supply of Activase 50 mg vials. This firm fixed price contract, issued on July 18, 2025, with an ultimate completion date of July 21, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX). The award was made through competitive procurement with no set-aside designation. Performance will take place at...